Mette Kirstine Agger, Director at Trevi Therapeutics, Inc. (TRVI), bought 1,151,544 shares at $10.00 ($3.8M) on 2019-05-09, disclosed to the SEC on 2019-05-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 776,544 | $0 | 0.0% |
| 2 | $10.00 | 375,000 | $3.8M | 100.0% |
| Total | $3.26 avg | 1,151,544 | $3.8M | 100% |
| Filing → |